Hyperemesis Gravidarum
Recent clinical, regulatory, research and industry developments relating to this disease.
Maternal hepatic immunology during pregnancy.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Cholestasis, Intrahepatic1
- Fatty Liver1
- Hyperemesis Gravidarum1
- Pre-Eclampsia1
Leading journals1
- Frontiers in immunology1
Leading researchers5
- Fang H1
- Meng Y1
- Shi Y1
- Yang L1
- Zhang L1
Affiliations (unnormalised)1
- School of Life Sciences and Food Engineering1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
Intractable VOMITING that develops in early PREGNANCY and persists. This can lead to DEHYDRATION and WEIGHT LOSS.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.